Browse by Author or creator
2025
Binici, Burcu and Rattray, Zahra and Zinger, Assaf and Perrie, Yvonne (2025) Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs : a combined in vitro and preclinical perspective. Journal of Controlled Release, 377. pp. 162-173. ISSN 0168-3659
2024
Binici, Burcu and Borah, Ankita and Watts, Julie A and McLoughlin, Daragh and Perrie, Yvonne (2024) The influence of citrate buffer molarity in mRNA-LNPs : exploring factors beyond general critical quality attributes. International Journal of Pharmaceutics. 124942. ISSN 1873-3476
Hussain, Muattaz and Binici, Burcu and O'Connor, Liam and Perrie, Yvonne (2024) Production of mRNA lipid nanoparticles using advanced crossflow micromixing. Journal of Pharmacy and Pharmacology. rgae122. ISSN 0022-3573
McMillan, Caitlin and Druschitz, Amy and Rumbelow, Stephen and Borah, Ankita and Binici, Burcu and Rattray, Zahra and Perrie, Yvonne (2024) Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC Pharmaceutics, 1 (4). pp. 841-853. ISSN 2976-8713
Binici, Burcu and Rattray, Zahra and Schroeder, Avi and Perrie, Yvonne (2024) The role of biological sex in pre-clinical (mouse) mRNA vaccine studies. Vaccines, 12 (3). 282. ISSN 2076-393X
2022
Plant-Hately, Alexander J. and Eryilmaz, Burcu and David, Christopher A. W. and Brain, Danielle E. and Heaton, Bethany J. and Perrie, Yvonne and Liptrott, Neill J. (2022) Exposure of the basophilic cell line KU812 to liposomes reveals activation profiles associated with potential anaphylactic responses linked to physico-chemical characteristics. Pharmaceutics, 14 (11). 2470. ISSN 1999-4923
Webb, Cameron and Ip, Shell and Bathula, Nuthan V. and Popova, Petya and Soriano, Shekinah K. V. and Ly, Han Han and Eryilmaz, Burcu and Nguyen Huu, Viet Anh and Broadhead, Richard and Rabel, Martin and Villamagna, Ian and Abraham, Suraj and Raeesi, Vahid and Thomas, Anitha and Clarke, Samuel and Ramsay, Euan C. and Perrie, Yvonne and Blakney, Anna K. (2022) Current status and future perspectives on MRNA drug manufacturing. Molecular Pharmaceutics, 19 (4). pp. 1047-1058. ISSN 1543-8384